The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for this market include the large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.

The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segments, the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.

9 Global Vascular Closure Devices Market, By Region (Page No. - 57) 9.1 Introduction 9.2 North America 9.2.1 U.S. 9.2.1.1 Rising Prevalence of Cardiovascular Diseases 9.2.1.2 Growing Trend of One-Day Surgeries for Vascular Procedures 9.2.1.3 Increase in Research and Clinical Trials for Vascular Closure Devices 9.2.1.4 Increasing Number of Conferences, Meetings, Symposia, and Workshops 9.2.2 Canada 9.2.2.1 Increasing Number of Cardiac Arrest Cases 9.2.2.2 Long Waiting Times for Cardiac Surgery Likely to Encourage the Adoption of Minimally Invasive Procedures 9.3 Europe 9.3.1 Increasing Focus of Market Players in the European Region 9.3.2 E-3 9.3.2.1 Increasing Number of Research Studies on Vascular Closure Devices in Germany 9.3.2.2 Rising Prevalence of CVDS in Germany 9.3.2.3 Increase in the Number of Radial Access Procedures in France and the U.K. 9.3.2.4 Growth in the Aging and Obese Populations in the U.K. 9.3.3 RoE 9.4 Asia-Pacific 9.4.1 Rapid Growth in the Aging Population in Japan & China 9.4.2 Cost—A Major Concern for Interventional Procedures in India 9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan 9.5 Rest of the World

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent.

In this report, the market has been segmented based on type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Passive approximators are expected to account for the largest share of the market in 2017. Passive approximators are the most widely used vascular closure devices in the market owing to the wide range of advantages associated with them, including increased safety and fewer complications than manual procedures.

The access segment includes femoral access and radial access. The femoral access segment is estimated to account for the largest share of the market in 2017 owing to the widespread preference for this access route among cardiologists and physicians during interventional procedures as well as the fewer complications involved during arterial access.

The procedures segment of the vascular closure devices market includes interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to hold the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases and increasing obese population across the globe.

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and increasing research and clinical trials for vascular closure devices.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.